$110.45
0.040.04%
Last update: Nov 3, 4:00 PM
BillionToOne Inc (BLLN) Stock Price, Quote, News & History
BLLNNASDAQ
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
You can purchase shares of BillionToOne (NASDAQ:BLLN) through any online brokerage.
Other companies in BillionToOne’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
BillionToOne has a consensus price target of $126.25.
The stock price for BillionToOne (NASDAQ: BLLN) is $110.45 last updated November 3, 2026 at 4:00 PM EST.
There are no upcoming dividends for BillionToOne.
BillionToOne does not have any upcoming earnings scheduled.
There is no upcoming split for BillionToOne.
BillionToOne is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT)...
